Hyalobarrier is a medical device by the biggest producer of hyaluronic products in the world Anika Therapeutics designed for the prevention of post-surgical adhesions, especially in obstetric – laparoscopic or open surgery.
Hyalobarrier is applied in surgery for endometriosis, myoma, ovary and fallopian tube operations, Asherman’s syndrome, post-Caesarean section etc.
Hyalobarrier is a sterile, transparent, highly viscose gel based on hyaluronic acid, which physically separates tissues.
Hyalobarrier remains in the area of application for 7 days, protecting the organism during the 3-5 days of adhesion risk and completely degrades up to 30 days (bioabsorbable).
Hyalobarrier is produced through biofermentation; it is not of animal origin, but a completely natural product, because of which it is applied in Caesarean section.
Hyalobarrier is the only product – choice in hysteroscopic surgery.
Hyalobarrier has proven efficacy through a large number of clinical trials; during the period 2000-2014 it was applied to over 100 000 patients, with no adverse effects being reported (infections, foreign body reactions).
For more information: www.srastvania.bg